Asymmetry Capital Management, L.P. - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 73 filers reported holding ENDOCYTE INC in Q4 2017. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.

Quarter-by-quarter ownership
Asymmetry Capital Management, L.P. ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$1,710,000
+20.1%
96,297
-6.7%
1.58%
+12.9%
Q2 2018$1,424,000
+71.4%
103,159
+12.8%
1.40%
+34.7%
Q1 2018$831,000
+138.1%
91,435
+12.2%
1.04%
+119.2%
Q4 2017$349,00081,4840.47%
Other shareholders
ENDOCYTE INC shareholders Q4 2017
NameSharesValueWeighting ↓
RA Capital Management 3,364,648$14,401,0001.20%
Asymmetry Capital Management, L.P. 81,484$349,0000.47%
PFM Health Sciences, LP 3,441,594$14,730,0000.35%
Perceptive Advisors 1,451,700$6,213,0000.21%
Leisure Capital Management 28,304$121,0000.10%
Cribstone Capital Management, LLC 47,349$203,0000.10%
EAM Investors, LLC 98,034$420,0000.08%
SG3 Management, LLC 32,500$139,0000.05%
Baker Brothers Advisors 1,087,323$4,654,0000.04%
Alpine Global Management, LLC 33,675$144,0000.03%
View complete list of ENDOCYTE INC shareholders